Episode 1 of 4 It’s Time To Understand CAR-T Therapy For B-Cell Lymphoma: Earlier Indications Coming To A Community Near You

1.0 hr(s) | Case Managers , CME , CPE , NCPD , Physician Assistants , Social Worker

Specialty: B-cell Malignancies , Lymphoma

Therapeutic Area(s): CAR T , Hematology, Malignant

Release Date: February 24, 2022

Expiration Date: April 8, 2023

Location: Internet Activity Enduring

It’s time to understand CAR-T therapy for B-cell lymphoma: Earlier indications coming to a community near you, episode 1 of the 4-part educational initiative, The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes, is designed for community-based oncology clinicians. This CE activity includes conversations among CAR-T experts and a community clinician; it includes animations, patient video clips, and numerous downloadable resources including a directory of CAR-T treatment centers organized by state.
This activity explains what CAR-T therapy is and how it works; a special guest highlights key data from completed and ongoing trials of CAR-T therapies that were presented during the recent hematology conference.

Access this activity
Share via
Copy link
Powered by Social Snap